share_log

BTIG Maintains Buy on Xtant Medical Hldgs, Raises Price Target to $3

Benzinga ·  May 16 22:13

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $2 to $3.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment